Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	DCHS2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 CUBN TENM2 PCDHGA12 ACAN PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	1.19e-11	749	129	25	GO:0005509
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DCHS2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	2.98e-22	187	126	22	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	DCHS2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 ADGRL1 TENM2 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	9.08e-20	313	126	24	GO:0098742
GeneOntologyBiologicalProcess	cell-cell adhesion	DCHS2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PRICKLE1 PCDHGB2 PCDHGB1 ABCA12 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 RC3H1 PKD1L1 ADGRL1 ITGA1 TENM2 PCDHGA12 PCDH11X PCDHGB4 KIRREL1 PCDHGC3 PCDHGA8	1.66e-12	1077	126	30	GO:0098609
MousePheno	expanded mesangial matrix	MYO1E ESR1 ITGA1 ADAR KIRREL1	9.86e-06	46	88	5	MP:0011353
MousePheno	abnormal mesangial matrix morphology	MYO1E ESR1 ITGA1 ADAR KIRREL1	1.65e-05	51	88	5	MP:0011338
Domain	Cadherin_tail	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGB4 PCDHGC3 PCDHGA8	1.35e-34	37	127	20	PF15974
Domain	Cadherin_CBD	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGB4 PCDHGC3 PCDHGA8	1.35e-34	37	127	20	IPR031904
Domain	Cadherin_C	PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGB4 PCDHGC3 PCDHGA8	6.32e-31	42	127	19	IPR032455
Domain	Cadherin_C_2	PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGB4 PCDHGC3 PCDHGA8	6.32e-31	42	127	19	PF16492
Domain	Cadherin_2	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	2.55e-30	65	127	21	PF08266
Domain	Cadherin_N	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	2.55e-30	65	127	21	IPR013164
Domain	Cadherin	DCHS2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 FREM1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	1.80e-27	118	127	23	IPR002126
Domain	Cadherin_CS	DCHS2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	1.15e-26	109	127	22	IPR020894
Domain	CADHERIN_1	DCHS2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	2.72e-26	113	127	22	PS00232
Domain	Cadherin	DCHS2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	2.72e-26	113	127	22	PF00028
Domain	CADHERIN_2	DCHS2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	3.35e-26	114	127	22	PS50268
Domain	-	DCHS2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	3.35e-26	114	127	22	2.60.40.60
Domain	CA	DCHS2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	4.12e-26	115	127	22	SM00112
Domain	Cadherin-like	DCHS2 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	5.06e-26	116	127	22	IPR015919
Domain	Factor_5/8	F5 F8	4.59e-05	2	127	2	IPR024715
Domain	RFX1_trans_act	RFX1 RFX2	1.37e-04	3	127	2	IPR007668
Domain	RFX1_trans_act	RFX1 RFX2	1.37e-04	3	127	2	PF04589
Domain	FA58C	F5 F8 DCBLD2	3.73e-04	21	127	3	SM00231
Domain	FA58C_3	F5 F8 DCBLD2	3.73e-04	21	127	3	PS50022
Domain	FA58C_1	F5 F8 DCBLD2	3.73e-04	21	127	3	PS01285
Domain	FA58C_2	F5 F8 DCBLD2	3.73e-04	21	127	3	PS01286
Domain	Cupredoxin	PRPF8 F5 F8	4.30e-04	22	127	3	IPR008972
Domain	Cu-oxidase_3	F5 F8	4.53e-04	5	127	2	IPR011707
Domain	HnRNP-L/PTB	PTBP2 HNRNPLL	4.53e-04	5	127	2	IPR006536
Domain	MULTICOPPER_OXIDASE1	F5 F8	4.53e-04	5	127	2	PS00079
Domain	Cu_oxidase_CS	F5 F8	4.53e-04	5	127	2	IPR033138
Domain	Cu-oxidase_3	F5 F8	4.53e-04	5	127	2	PF07732
Domain	F5_F8_type_C	F5 F8 DCBLD2	5.60e-04	24	127	3	PF00754
Domain	FA58C	F5 F8 DCBLD2	5.60e-04	24	127	3	IPR000421
Domain	Cu_oxidase_Cu_BS	F5 F8	6.76e-04	6	127	2	IPR002355
Domain	Myosin_TH1	MYO1E MYO1F	9.42e-04	7	127	2	PF06017
Domain	Myosin_TH1	MYO1E MYO1F	9.42e-04	7	127	2	IPR010926
Domain	TH1	MYO1E MYO1F	9.42e-04	7	127	2	PS51757
Domain	EPL1	BRPF3 BRD1	1.25e-03	8	127	2	PF10513
Domain	Enhancer_polycomb-like_N	BRPF3 BRD1	1.25e-03	8	127	2	IPR019542
Domain	-	F5 F8 DCBLD2 EPHA1	1.54e-03	73	127	4	2.60.120.260
Domain	RFX_DNA_binding	RFX1 RFX2	1.60e-03	9	127	2	PF02257
Domain	DNA-bd_RFX	RFX1 RFX2	1.60e-03	9	127	2	IPR003150
Domain	RFX_DBD	RFX1 RFX2	1.60e-03	9	127	2	PS51526
Domain	ThiF_NAD_FAD-bd	UBA1 NAE1	1.99e-03	10	127	2	IPR000594
Domain	ThiF	UBA1 NAE1	1.99e-03	10	127	2	PF00899
Domain	BROMODOMAIN_1	BRPF3 ATAD2 BRD1	2.02e-03	37	127	3	PS00633
Domain	Bromodomain	BRPF3 ATAD2 BRD1	2.18e-03	38	127	3	PF00439
Domain	BROMODOMAIN_2	BRPF3 ATAD2 BRD1	2.71e-03	41	127	3	PS50014
Domain	ABC_A	ABCA2 ABCA12	2.90e-03	12	127	2	IPR026082
Domain	Bromodomain	BRPF3 ATAD2 BRD1	2.90e-03	42	127	3	IPR001487
Domain	BROMO	BRPF3 ATAD2 BRD1	2.90e-03	42	127	3	SM00297
Domain	-	BRPF3 ATAD2 BRD1	2.90e-03	42	127	3	1.20.920.10
Domain	SH3	MPP3 ARHGAP32 MYO1E NOXA1 MYO1F ARHGEF37	3.62e-03	216	127	6	SM00326
Domain	SH3	MPP3 ARHGAP32 MYO1E NOXA1 MYO1F ARHGEF37	3.62e-03	216	127	6	PS50002
Domain	Galactose-bd-like	F5 F8 DCBLD2 EPHA1	3.88e-03	94	127	4	IPR008979
Domain	SH3_domain	MPP3 ARHGAP32 MYO1E NOXA1 MYO1F ARHGEF37	3.96e-03	220	127	6	IPR001452
Domain	-	F5 F8	3.96e-03	14	127	2	2.60.40.420
Domain	PROTEIN_KINASE_TYR	LMTK2 AATK ROS1 EPHA1	4.34e-03	97	127	4	PS00109
Domain	Tyr_kinase_AS	LMTK2 AATK ROS1 EPHA1	4.34e-03	97	127	4	IPR008266
Domain	CUB	CUBN CSMD1 DCBLD2	4.50e-03	49	127	3	PF00431
Domain	CUB	CUBN CSMD1 DCBLD2	4.77e-03	50	127	3	SM00042
Domain	SH3_1	ARHGAP32 MYO1E NOXA1 MYO1F ARHGEF37	5.28e-03	164	127	5	PF00018
Domain	-	CUBN CSMD1 DCBLD2	5.32e-03	52	127	3	2.60.120.290
Domain	CUB	CUBN CSMD1 DCBLD2	5.61e-03	53	127	3	PS01180
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	2.50e-34	74	130	21	10817752
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	6.53e-34	77	130	21	10835267
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	1.64e-33	80	130	21	10716726
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGB4 PCDHGC3 PCDHGA8	4.34e-33	68	130	20	11230163
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGB4 PCDHGC3 PCDHGA8	1.63e-32	72	130	20	10380929
Pubmed	Maturation of postnatally generated olfactory bulb granule cells depends on functional γ-protocadherin expression.	PCDHGC5 PCDHGB5 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA12 PCDHGB4 PCDHGC3	1.56e-30	15	130	13	23515096
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHGC5 PCDHGB5 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA12 PCDHGB4 PCDHGC3	5.35e-25	28	130	13	15347688
Pubmed	A differential developmental pattern of spinal interneuron apoptosis during synaptogenesis: insights from genetic analyses of the protocadherin-gamma gene cluster.	PCDHGC5 PCDHGB5 MNX1 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA12 PCDHGB4 PCDHGC3	5.28e-24	44	130	14	19029045
Pubmed	Functional significance of isoform diversification in the protocadherin gamma gene cluster.	PCDHGC5 PCDHGB5 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA12 PCDHGB4 PCDHGC3	1.30e-23	34	130	13	22884324
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHGC5 PCDHGB5 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA12 PCDHGB4 PCDHGC3	3.20e-20	57	130	13	32633719
Pubmed	Differential expression of individual gamma-protocadherins during mouse brain development.	PCDHGC5 PCDHGA4 PCDHGA3 PCDHGA12 PCDHGB4 PCDHGC3	1.69e-14	7	130	6	15964765
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHGC5 PCDHGB2 PCDHGA10 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGB4 PCDHGC3	9.81e-13	58	130	9	30377227
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PTBP2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 YBX3 PRPF8 AP1AR PCDHGA12 PABPC3 PCDHGB4 PCDHGC3 PCDHGA8	1.32e-10	1442	130	25	35575683
Pubmed	Molecular mechanisms governing Pcdh-gamma gene expression: evidence for a multiple promoter and cis-alternative splicing model.	PCDHGC5 PCDHGB2 PCDHGA12 PCDHGB4	2.31e-08	9	130	4	12154121
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHGB2 PCDHGA10 PCDHGA3 PCDHGC3	1.87e-06	24	130	4	24698270
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	ARHGAP32 ADGRL1 GALNT16 NF1 ACAN PABPC3 G3BP2 MYO1F CCDC15 SERAC1	5.36e-06	430	130	10	32581705
Pubmed	Docking motif-guided mapping of the interactome of protein phosphatase-1.	DDX31 CSRNP3 PCDH11X CSMD1 HYDIN	1.30e-05	80	130	5	19389623
Pubmed	Membrane-cytoskeletal crosstalk mediated by myosin-I regulates adhesion turnover during phagocytosis.	MYO1E MYO1F	1.39e-05	2	130	2	30890704
Pubmed	Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial.	F5 F8	1.39e-05	2	130	2	26599105
Pubmed	Blood group AB and factor V Leiden as risk factors for pre-eclampsia: a population-based nested case-control study.	ABO F5	1.39e-05	2	130	2	19110300
Pubmed	The molecular basis of factor V and VIII procofactor activation.	F5 F8	1.39e-05	2	130	2	19765210
Pubmed	Localization of mouse phenylalanine hydroxylase locus on chromosome 10.	TYR PAH	1.39e-05	2	130	2	3378451
Pubmed	Estrogen-ERα signaling and DNA hypomethylation co-regulate expression of stem cell protein PIWIL1 in ERα-positive endometrial cancer cells.	ESR1 PIWIL1	1.39e-05	2	130	2	32503542
Pubmed	Repression of E1AF transcriptional activity by sumoylation and PIASy.	ETV4 PIAS4	1.39e-05	2	130	2	17585876
Pubmed	Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking.	F5 F8	1.39e-05	2	130	2	28057741
Pubmed	A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.	ABO F8	1.39e-05	2	130	2	17209060
Pubmed	The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels.	F5 F8	1.39e-05	2	130	2	15735794
Pubmed	Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism.	F5 F8	1.39e-05	2	130	2	17287628
Pubmed	ETV4 Is Necessary for Estrogen Signaling and Growth in Endometrial Cancer Cells.	ESR1 ETV4	1.39e-05	2	130	2	32046982
Pubmed	Activated protein C has a regulatory role in factor VIII function.	F5 F8	1.39e-05	2	130	2	33512448
Pubmed	Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers.	F5 F8	1.39e-05	2	130	2	11091190
Pubmed	Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer.	ESR1 NF1	1.39e-05	2	130	2	32142667
Pubmed	ROS1-Rearranged Non-Small-Cell Lung Cancer, Factor V Leiden, and Recurrent Venous Thromboses.	F5 ROS1	1.39e-05	2	130	2	29945753
Pubmed	Involvement of BREK, a serine/threonine kinase enriched in brain, in NGF signalling.	LMTK2 AATK	1.39e-05	2	130	2	15005709
Pubmed	Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity.	F5 F8	1.39e-05	2	130	2	22613792
Pubmed	The genes for MHC class II regulatory factors RFX1 and RFX2 are located on the short arm of chromosome 19.	RFX1 RFX2	1.39e-05	2	130	2	1505960
Pubmed	The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes.	ABO F5	1.39e-05	2	130	2	18028481
Pubmed	Myo1f has an essential role in γδT intraepithelial lymphocyte adhesion and migration.	MYO1E MYO1F	1.39e-05	2	130	2	37207213
Pubmed	Proteolytically released Lasso/teneurin-2 induces axonal attraction by interacting with latrophilin-1 on axonal growth cones.	ADGRL1 TENM2	1.39e-05	2	130	2	30457553
Pubmed	Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding.	ESR1 RFX1	1.39e-05	2	130	2	10706293
Pubmed	The Rho exchange factor Net1 is regulated by nuclear sequestration.	NET1 ARHGEF3	1.39e-05	2	130	2	11839749
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MPP3 SEMA6B ABCA2 ARSJ MYO1E SZT2 INPPL1 LMTK2 ADGRL1 PAPLN MPRIP PIAS4 AATK DTX2 TNPO3	1.73e-05	1105	130	15	35748872
Pubmed	Mapping of unconventional myosins in mouse and human.	MYO1E TYR NF1 MYO1F	3.19e-05	48	130	4	8884266
Pubmed	A genetic linkage map of mouse chromosome 10: localization of eighteen molecular markers using a single interspecific backcross.	ESR1 PAH ROS1	3.34e-05	17	130	3	1975791
Pubmed	ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.	ESR1 ATAD2	4.15e-05	3	130	2	17998543
Pubmed	Involvement of RFX proteins in transcriptional activation from a Ras-responsive enhancer element.	RFX1 RFX2	4.15e-05	3	130	2	15024578
Pubmed	Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains.	RFX1 RFX2	4.15e-05	3	130	2	10330134
Pubmed	Ciliogenic RFX transcription factors regulate FGF1 gene promoter.	RFX1 RFX2	4.15e-05	3	130	2	22415835
Pubmed	Factor V Leiden improves in vivo hemostasis in murine hemophilia models.	F5 F8	4.15e-05	3	130	2	16359510
Pubmed	The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism.	ABO F8	4.15e-05	3	130	2	15735796
Pubmed	Cis-acting regulation of splenic Art2 gene expression in inbred mouse strains.	TYR ACAN	4.15e-05	3	130	2	10369930
Pubmed	Coagulation procofactor activation by factor XIa.	F5 F8	4.15e-05	3	130	2	20456758
Pubmed	A novel cytokine pathway suppresses glial cell melanogenesis after injury to adult nerve.	TYR NF1	4.15e-05	3	130	2	12427839
Pubmed	Factor V Leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study.	F5 F8	4.15e-05	3	130	2	25592075
Pubmed	Drosophila regulatory factor X is necessary for ciliated sensory neuron differentiation.	RFX1 RFX2	4.15e-05	3	130	2	12403718
Pubmed	Global characterization of transcriptional impact of the SRC-3 coregulator.	ESR1 RFX1	4.15e-05	3	130	2	20181721
Pubmed	Structural and functional analysis of the apoptosis-associated tyrosine kinase (AATYK) family.	LMTK2 AATK	4.15e-05	3	130	2	17651901
Pubmed	Interplay of RFX transcription factors 1, 2 and 3 in motile ciliogenesis.	RFX1 RFX2	4.15e-05	3	130	2	32725242
Pubmed	22 genes from chromosome 17q21: cloning, sequencing, and characterization of mutations in breast cancer families and tumors.	ETV4 EZH1	4.15e-05	3	130	2	7774926
Pubmed	Complete coding sequence, deduced primary structure, chromosomal localization, and structural analysis of murine aggrecan.	TYR ACAN	4.15e-05	3	130	2	7806222
Pubmed	Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene.	TYR ACAN	4.15e-05	3	130	2	9808625
Pubmed	Interpretation of correlations between coagulation factors FV, FVIII and vWF in normal and type 2 diabetes mellitus patients.	F5 F8	4.15e-05	3	130	2	22032085
Pubmed	Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.	F5 F8	4.15e-05	3	130	2	12368162
Pubmed	A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.	ABO F5	4.15e-05	3	130	2	22672568
Pubmed	[ABO/H blood groups and factor V Leiden].	ABO F5	4.15e-05	3	130	2	11998221
Pubmed	Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation.	F5 F8	4.15e-05	3	130	2	21774968
Pubmed	Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women.	ABO F8	4.15e-05	3	130	2	16956829
Pubmed	AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.	ABO F5	4.15e-05	3	130	2	18387978
Pubmed	Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.	ABO F5	4.15e-05	3	130	2	23382263
Pubmed	Domain-functional analyses of PIWIL1 and PABPC1 indicate their synergistic roles in protein translation via 3'-UTRs of meiotic mRNAs.	PIWIL1 PABPC3	4.15e-05	3	130	2	29701755
Pubmed	RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins.	RFX1 RFX2	4.15e-05	3	130	2	8289803
Pubmed	Cytoplasmic poly(A)-binding protein 1 (PABPC1) interacts with the RNA-binding protein hnRNPLL and thereby regulates immunoglobulin secretion in plasma cells.	PABPC3 HNRNPLL	4.15e-05	3	130	2	28611064
Pubmed	Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups.	ABO F5	4.15e-05	3	130	2	21070754
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	PCBP3 PTBP2 PIWIL1 PRPF8 ADAR PABPC3 G3BP2 HNRNPLL	5.12e-05	347	130	8	16033648
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	DDX31 PTBP2 PCDHGA9 RC3H1 YBX3 LARP4 PRPF8 ADAR UBA1 G3BP2 EIF3L HNRNPLL	5.32e-05	807	130	12	22681889
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	PCBP3 PDK1 YBX3 ADAR TENM2 PABPC3 G3BP2 SERAC1 HNRNPLL	6.36e-05	462	130	9	31138677
Pubmed	ADAR1 mediated regulation of neural crest derived melanocytes and Schwann cell development.	DRP2 ADAR TYR UGT8	7.23e-05	59	130	4	31924792
Pubmed	Class I myosin Myo1e regulates TLR4-triggered macrophage spreading, chemokine release, and antigen presentation via MHC class II.	MYO1E MYO1F	8.28e-05	4	130	2	25263281
Pubmed	Human regulatory factor X 4 (RFX4) is a testis-specific dimeric DNA-binding protein that cooperates with other human RFX members.	RFX1 RFX2	8.28e-05	4	130	2	11682486
Pubmed	Differential expression of Rfx1-4 during mouse spermatogenesis.	RFX1 RFX2	8.28e-05	4	130	2	19596083
Pubmed	EF-hand domains of MCFD2 mediate interactions with both LMAN1 and coagulation factor V or VIII.	F5 F8	8.28e-05	4	130	2	20007547
Pubmed	ABO blood groups and genetic risk factors for thrombosis in Croatian population.	ABO F5	8.28e-05	4	130	2	20017223
Pubmed	Variant mapping and mutation discovery in inbred mice using next-generation sequencing.	ABCA12 ADAR	8.28e-05	4	130	2	26552429
Pubmed	Transcriptional regulation of the Alström syndrome gene ALMS1 by members of the RFX family and Sp1.	RFX1 RFX2	8.28e-05	4	130	2	20381594
Pubmed	Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin.	F5 F8	8.28e-05	4	130	2	9525969
Pubmed	Maternal IVS1-401 T allele of the estrogen receptor alpha is an independent predictor of late fetal loss.	ESR1 F5	8.28e-05	4	130	2	16753154
Pubmed	Structural characterization of carbohydrate binding by LMAN1 protein provides new insight into the endoplasmic reticulum export of factors V (FV) and VIII (FVIII).	F5 F8	8.28e-05	4	130	2	23709226
Pubmed	The Chromatin Regulator BRPF3 Preferentially Activates the HBO1 Acetyltransferase but Is Dispensable for Mouse Development and Survival.	BRPF3 BRD1	8.28e-05	4	130	2	26677226
Pubmed	Planar cell polarity-dependent asymmetric organization of microtubules for polarized positioning of the basal body in node cells.	DCHS2 PRICKLE1	8.28e-05	4	130	2	35420656
Pubmed	Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex.	F5 F8	8.28e-05	4	130	2	12717434
Pubmed	Prothrombotic polymorphisms in patients with Raynaud's phenomenon and migraine.	F5 F8	8.28e-05	4	130	2	23238545
Pubmed	The RFX family interacts at the collagen (COL1A2) start site and represses transcription.	RFX1 RFX2	8.28e-05	4	130	2	11986307
Pubmed	Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.	ABO F5	8.28e-05	4	130	2	19278955
Pubmed	BRCA1 suppresses osteopontin-mediated breast cancer.	ESR1 ETV4	8.28e-05	4	130	2	16807234
Pubmed	Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V.	F5 F8	8.28e-05	4	130	2	18424440
Pubmed	The b1 isoform of protocadherin-gamma (Pcdhgamma) interacts with the microtubule-destabilizing protein SCG10.	PCDHGB2 PCDHGB1	8.28e-05	4	130	2	15581637
Pubmed	cTag-PAPERCLIP Reveals Alternative Polyadenylation Promotes Cell-Type Specific Protein Diversity and Shifts Araf Isoforms with Microglia Activation.	PTBP2 PABPC3	8.28e-05	4	130	2	28910620
Pubmed	Combined deficiency of coagulation factors V and VIII: an update.	F5 F8	8.28e-05	4	130	2	23852824
Pubmed	Galnt11 regulates kidney function by glycosylating the endocytosis receptor megalin to modulate ligand binding.	GALNT1 CUBN GALNT16	9.75e-05	24	130	3	31740596
Pubmed	Hundreds of variants clustered in genomic loci and biological pathways affect human height.	PAPPA2 ESR1 ZNF462 ACAN MYO1F TNS1	1.05e-04	198	130	6	20881960
Interaction	H2BC5 interactions	PCDHGC5 PCDHGC4 PCDHGB7 MYO1E PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 ESR1 PRPF8 GALNT16 PCDHGA12 PCDHGB4 PCDHGC3 PCDHGA8	1.01e-18	331	129	24	int:H2BC5
Interaction	PCDHGB2 interactions	PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA6 PCDHGA12 PCDHGB4 PCDHGC3 DCBLD2	4.97e-17	44	129	12	int:PCDHGB2
Interaction	PCDHGA4 interactions	PCDHGB7 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA12 PCDHGC3 PCDHGA8	1.21e-16	34	129	11	int:PCDHGA4
Interaction	PCDHGB1 interactions	PCDHGC4 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PDK1 PCDHGA9 PCDHGA7 ADGRL1 PCDHGA12 PCDHGB4 PCDHGC3	7.26e-14	77	129	12	int:PCDHGB1
Interaction	PCDHGB3 interactions	PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGB4 PCDHGC3	1.70e-12	8	129	6	int:PCDHGB3
Interaction	PCDHGA12 interactions	PCDHGB2 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA4 PCDHGA12	1.26e-11	10	129	6	int:PCDHGA12
Interaction	PCDHA9 interactions	PCDHGB7 PCDHGB5 PCDHGB2 PCDHGA10 PCDHGA9 PCDHGA6 PCDHGA4 PCDHGA12	2.09e-11	32	129	8	int:PCDHA9
Interaction	PCDHGA9 interactions	PCDHGB2 PCDHGB1 PCDHGA9 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA12 PCDHGA8	2.75e-11	33	129	8	int:PCDHGA9
Interaction	PCDHGA7 interactions	PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA12	1.63e-10	25	129	7	int:PCDHGA7
Interaction	PCDHGA6 interactions	PCDHGB2 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGC3	7.49e-09	24	129	6	int:PCDHGA6
Interaction	PCDHGA8 interactions	PCDHGA9 PCDHGA5 PCDHGA4 PCDHGA8	7.97e-09	5	129	4	int:PCDHGA8
Interaction	LTBP1 interactions	PCDHGC5 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 ESR1 PCDHGB4	1.34e-07	92	129	8	int:LTBP1
Interaction	AREL1 interactions	PCDHGC4 PCDHGB2 PCDHGA5 PIAS4 PCDHGB4	7.17e-07	27	129	5	int:AREL1
Interaction	PCDHGC3 interactions	PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA6 PCDHGA4 PCDHGC3	1.23e-06	54	129	6	int:PCDHGC3
Interaction	PCDHGA5 interactions	PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA8	3.08e-06	63	129	6	int:PCDHGA5
Interaction	PCDHGB7 interactions	PCDHGB7 PCDHGB2 PCDHGA4	5.05e-06	6	129	3	int:PCDHGB7
Interaction	PCDHGA10 interactions	PCDHGB2 PCDHGA10 PCDHGA7 PCDHGA4	5.76e-06	19	129	4	int:PCDHGA10
Interaction	PCDHGB5 interactions	PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGB4	7.87e-06	43	129	5	int:PCDHGB5
Interaction	RYK interactions	PCDHGC4 PCDHGB5 PCDHGA7 PCDHGA6 PCDHGA5 F5 PCDHGA12 KIRREL1 PCDHGC3	9.17e-06	212	129	9	int:RYK
Interaction	HLA-DRA interactions	SEMA6B ABCA2 GALNT1 UGT8 SLC39A6 SERAC1 DCBLD2 EPHA1	1.17e-05	166	129	8	int:HLA-DRA
Interaction	CBX6 interactions	DDX31 PCDHGC4 PCDHGB5 PCDHGB2 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA4 YBX3 PCDHGB4	1.44e-05	283	129	10	int:CBX6
Interaction	PCDHGA3 interactions	PCDHGA9 PCDHGA4 PCDHGA3	2.09e-05	9	129	3	int:PCDHGA3
Interaction	PCDHB3 interactions	SEMA6B ABCA2 PCDHGB5 PCDHGB2 PCDHGA10 PCDHGA5 SLC39A6	3.47e-05	141	129	7	int:PCDHB3
Interaction	PCDHGB4 interactions	PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGB4	3.77e-05	59	129	5	int:PCDHGB4
Interaction	RPL23 interactions	PCDHGC5 PCDHGC4 PCDHGB5 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 RC3H1 PRPF8 G3BP2 PCDHGB4	4.39e-05	540	129	13	int:RPL23
Interaction	C2CD2L interactions	PCDHGC4 PCDHGB5 PCDHGB2 PCDHGB1 ESR1 PCDHGB4	8.41e-05	112	129	6	int:C2CD2L
Cytoband	5q31	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGB4 PCDHGC3 PCDHGA8	2.21e-30	115	130	20	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGB4 PCDHGC3 PCDHGA8	8.17e-22	298	130	20	chr5q31
GeneFamily	Clustered protocadherins	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGB4 PCDHGC3 PCDHGA8	6.27e-31	64	96	20	20
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	DDX31 LMTK2 AATK CSRNP3 PCDH11X CSMD1 TNS1 HYDIN	5.41e-06	181	96	8	694
GeneFamily	Myosins, class I	MYO1E MYO1F	7.65e-04	8	96	2	1097
GeneFamily	Regulatory factor X family	RFX1 RFX2	7.65e-04	8	96	2	1153
GeneFamily	Ubiquitin like modifier activating enzymes	UBA1 NAE1	1.22e-03	10	96	2	100
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	LMTK2 AATK ROS1	1.24e-03	40	96	3	321
GeneFamily	ATP binding cassette subfamily A	ABCA2 ABCA12	2.44e-03	14	96	2	805
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	PAPPA2 ACAN CSMD1	3.45e-03	57	96	3	1179
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNT1 GALNT16	4.98e-03	20	96	2	433
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	NET1 ARHGEF3 ARHGEF37	5.21e-03	66	96	3	722
GeneFamily	PWWP domain containing	BRPF3 BRD1	6.01e-03	22	96	2	1147
Coexpression	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDH11X PCDHGB4 PCDHGC3 PCDHGA8	8.04e-11	222	129	13	M16955
Coexpression	GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP	ABCA12 PDK1 CUBN TYR EIF3L CKAP2L KIRREL1 TNPO3	4.22e-06	187	129	8	M6809
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-C\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDHGC5 PCDHGB3 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA4 PCDHGA2 PCDHGA1 PCDHGB4 PCDHGC3	1.65e-10	184	129	10	629cfed10e1112cf30f6a828ce9efbbc6b207789
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-C\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDHGC5 PCDHGC4 PCDHGB3 PCDHGB2 PCDHGA10 PCDHGA9 PCDHGA4 EIF3L PCDHGC3	3.88e-09	186	129	9	10edc3dd96181b6f7bd07a5ad0862ba9fa6a9cb9
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	DCHS2 ABO PCDHGB1 PCDHGA9 PCDHGA5 FREM1 PCDH11X PCDHGB4	3.02e-08	166	129	8	65dafed953b01a9830b54309af75c7a561e88336
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRP2 ABCA12 FREM1 PCDH11X ROS1 CSMD1 UNC79 HYDIN	6.72e-08	184	129	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRP2 ABCA12 FREM1 PCDH11X ROS1 CSMD1 UNC79 HYDIN	6.72e-08	184	129	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRP2 ABCA12 FREM1 PCDH11X ROS1 CSMD1 UNC79 HYDIN	6.72e-08	184	129	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	MYO1E MNX1 RFX2 FREM1 ZNF462 KIRREL1 UNC79 HYDIN	7.93e-08	188	129	8	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 ARSJ ABCA12 ASPHD2 ITGA1 PCDH11X ROS1	7.13e-07	172	129	7	cecfe5cf20f317ea01b4604789e07a14481c4cd6
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDHGC4 PCDHGB2 PCDHGA12 EIF3L PCDH11X UGT8 PCDHGC3	1.00e-06	181	129	7	493a0222923ea04dadf17927c208671a046cd6df
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_only / Treatment groups by lineage, cell group, cell type	NET1 ITGA1 TENM2 GALNT16 MPRIP ACAN CSMD1	1.95e-06	200	129	7	7c62678cf408aaaf98d6df0fb27814d2007c4521
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDK1 TAS1R3 PCDHGA6 PCDHGA3 PCDH11X UNC79	9.01e-06	166	129	6	a1009d25c5a500f470e8edb04097ac47d4d72f3c
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDK1 TAS1R3 PCDHGA6 PCDHGA3 PCDH11X UNC79	9.01e-06	166	129	6	5a6e3364d223829f66e8da7f3560d95fd8bb9b11
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDK1 TAS1R3 PCDHGA6 PCDHGA3 PCDH11X UNC79	9.01e-06	166	129	6	e25bcbb5b3ba453a6e2572637f2521a32223a3ad
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 ARSJ ETV4 ITGA1 FREM1 ROS1	9.98e-06	169	129	6	716e9d4c5fb99c56b76afaa5ed90bfa859fde802
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARSJ MNX1 ETV4 ITGA1 PCDH11X ROS1	9.98e-06	169	129	6	ccb7b2daa65cb5f4c1e7a48b3bcdf0cb8f7675c3
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 TAS1R3 CUBN CSRNP3 UNC79 HYDIN	9.98e-06	169	129	6	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 ARSJ ABCA12 ITGA1 PCDH11X ROS1	1.03e-05	170	129	6	84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	PRICKLE1 PAPLN SYNDIG1 KIRREL1 TNS1 DCBLD2	1.10e-05	172	129	6	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 ARSJ ABO GALNT16 PCDH11X ROS1	1.18e-05	174	129	6	e4d65fe121a32ac4cdd6312e7b8f867f0852e991
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NET1 ITGA1 GALNT16 MPRIP ACAN CSMD1	1.18e-05	174	129	6	015d3742d3d79a57413a333f00ef2d380a9848dd
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-3\|TCGA-Thymus / Sample_Type by Project: Shred V9	PCDHGC4 PCDHGB2 PCDHGA6 PCDHGA5 PCDHGA4	1.25e-05	103	129	5	91fe062dcadd12fdb04fa4593a794c57f3f0411d
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5\|TCGA-Colorectal / Sample_Type by Project: Shred V9	ARHGAP32 ARSJ GALNT1 MYO1E ABCA12 UGT8	1.47e-05	181	129	6	8fcc9e77fee7c248df26b6c59b10e672242e2084
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-B\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDHGC4 PCDHGB5 PCDHGB2 PCDHGA10 PCDHGA7 PCDHGA8	1.52e-05	182	129	6	f7b28744d9c330b6004763aa8aa8605ba41fd1fa
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDHGC4 PCDHGB2 EIF3L PCDH11X UGT8 PCDHGC3	1.57e-05	183	129	6	a742c9a33f32058f9fb051733e3e736bc704d8e6
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDHGC4 PCDHGB3 PCDHGB2 PCDHGA7 EIF3L PCDH11X	1.67e-05	185	129	6	d42dcc92a34fcdabf112565fbd5fd26cbd4de58a
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NET1 ITGA1 GALNT16 MPRIP ACAN CSMD1	1.94e-05	190	129	6	d6b3a92119b210974a32af3fe9875d60eb02761e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGAP32 TENM2 CSRNP3 PCDH11X CSMD1 UNC79	2.44e-05	198	129	6	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Sigmoid-(1)_T_cell-(14)_Tcm\|Sigmoid / shred on region, Cell_type, and subtype	PCDHGA2 F5 MPRIP PCDH11X ZNF418 EPHA1	2.51e-05	199	129	6	ec454fa22fb7f50a947bdf4c4bb6f0ba13f62b4c
ToppCell	Sigmoid-T_cell-Tcm\|Sigmoid / Region, Cell class and subclass	PCDHGA2 F5 MPRIP PCDH11X ZNF418 EPHA1	2.51e-05	199	129	6	f7c729eaa3c8fd5a05cb6f79cac9b8f199c8092b
ToppCell	Tracheal-10x5prime-Stromal-Schwann-Schwann_Myelinating\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA2 DRP2 PCDHGA3 CUBN AATK UGT8	2.51e-05	199	129	6	2b567b6fd8addf059bbf2b72c55a7647aefdc595
ToppCell	Neuronal-Excitatory-eE(FEZF2_SLC17A7)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DCHS2 ARSJ ABCA12 ITGA1 PCDH11X ROS1	2.59e-05	200	129	6	501cd2b4e55444fc5fdd93ebbcfc0616442b110b
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ITGA1 TENM2 GALNT16 MPRIP ACAN CSMD1	2.59e-05	200	129	6	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NET1 ITGA1 TENM2 GALNT16 ACAN CSMD1	2.59e-05	200	129	6	a3a1e35934d676c39f917652e50c502cb2f613c1
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYO1E ITGA1 TENM2 GALNT16 ACAN CSMD1	2.59e-05	200	129	6	c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	NET1 HROB CSRNP3 PCDH11X CKAP2L KIRREL1	2.59e-05	200	129	6	eac33be484dc443794e66e473f03e98406c2983e
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	ITGA1 TENM2 GALNT16 MPRIP ACAN CSMD1	2.59e-05	200	129	6	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PCDHGA2 ETV4 CUBN TENM2 FREM1 ACAN	2.59e-05	200	129	6	29054cf55e88e1ac81a562d8dd9af9b7c749321d
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Airway\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ETV4 DHX33 GALNT16 UNC79 EPHA1	3.07e-05	124	129	5	d88bce8a4f023d5b617b2e8e372a94bd1248d20d
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PCDHGB7 PCDHGB2 PCDHGB1 PCDHGA10 PAPLN	3.32e-05	126	129	5	f1f24b06d301c266226d1a59dd28585f5ac68f29
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PCDHGB7 PCDHGB2 PCDHGB1 PCDHGA10 PAPLN	3.32e-05	126	129	5	fe6900eb37e4f09465a1276586c73dd38545fa2a
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_TIP\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PCDHGB7 PCDHGB2 PCDHGB1 PCDHGA10 PAPLN	3.32e-05	126	129	5	3d507f829882d043f633db2612b76936e2042445
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PCDHGB7 PCDHGB2 PCDHGB1 PCDHGA10 PAPLN	3.32e-05	126	129	5	1ac4cc747e466bc79e33b97608b19ad29a7a6a41
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PCDHGB7 PCDHGB2 PCDHGB1 PCDHGA10 PAPLN	3.32e-05	126	129	5	2de551d7a8765afec1da8852727c79fec90f45f8
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCDHGB5 PCDHGA4 PKD1L1 EPHA1	8.62e-05	80	129	4	0d02b242164d27f38f70ed77b106612fc7a3abca
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCDHGB5 PCDHGA4 PKD1L1 EPHA1	8.62e-05	80	129	4	313344cf7309bc17ca131b92a91b24489df577e2
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Tmem2_(Tmem2)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCDHGB5 PCDHGA4 PKD1L1 EPHA1	8.62e-05	80	129	4	b95e4456adb7f7d42825351f010376c10bb35380
ToppCell	Control-Epithelial-Ionocyte\|Epithelial / Disease state, Lineage and Cell class	ATP6V1B1 PCBP3 SYNDIG1 FREM1 ARHGEF37	8.88e-05	155	129	5	4b9369b203a4d7071c56d3d8e6b450e9a0121c41
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 ARSJ ABO ITGA1 ROS1	1.19e-04	165	129	5	fee7f2f8d0e25c0d067adc73f8913721bd709a3e
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUBN ENTPD4 PAH UGT8 ALAS1	1.23e-04	166	129	5	8ab18c9d911eb3a9970bba7a769294b0927538f7
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 ARSJ ABCA12 ITGA1 ROS1	1.23e-04	166	129	5	739dfbe927f409821ff23aca6e47ebe78f57e859
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 ARSJ ITGA1 PCDH11X ROS1	1.26e-04	167	129	5	a6ff7a3d9b80839c0efa91658836812e868561fa
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHGA9 NOXA1 ETV4 UGT8 CSMD1	1.26e-04	167	129	5	cf6206c506715cd846799c62cf7c06e3fa99f7af
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PCBP3 ATAD2 HROB CCDC15 CKAP2L	1.26e-04	167	129	5	bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCell	droplet-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUBN ENTPD4 PAH UGT8 ALAS1	1.30e-04	168	129	5	dd48da83c32d41a62f80cd7e5e5c64e42776fa27
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E F5 TENM2 KIRREL1 ARHGEF3	1.30e-04	168	129	5	e96859dbf51cf8c4def8ee8db132f4d874fb4381
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 ARSJ ITGA1 PCDH11X ROS1	1.33e-04	169	129	5	2abdd8ae9a5d88aac30992142d1b502c959bc015
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHGA9 NOXA1 ETV4 UGT8 CSMD1	1.33e-04	169	129	5	30141f76e9bfc2b4586429857c72dbc85ba65cc9
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCDHGB7 PCDHGA7 PCDHGA3 PCDHGA1	1.36e-04	90	129	4	3817a5b0235e632d976ea565175bdbebbd959bf0
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCDHGB7 PCDHGA7 PCDHGA3 PCDHGA1	1.36e-04	90	129	4	a528f5dcee1a356dea89ff2588d2e0f276f2d5fc
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCHS2 ARHGAP32 PCBP3 PCDHGB5 PAPLN	1.37e-04	170	129	5	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 ATAD2 ACAN CCDC15 CKAP2L	1.41e-04	171	129	5	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	356C-Endothelial_cells-Endothelial-B_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PCDHGB7 PCDHGA5 MTM1 ARHGEF37 PCDHGA8	1.41e-04	171	129	5	6a2f88c2a62cb2f69797804e24eb1137a3e148de
ToppCell	356C-Endothelial_cells-Endothelial-B_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PCDHGB7 PCDHGA5 MTM1 ARHGEF37 PCDHGA8	1.41e-04	171	129	5	9be3554626408bb897d1f1c43b3ab4a92651f2e2
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TENM2 GALNT16 FREM1 ACAN CSMD1	1.41e-04	171	129	5	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA1 ATAD2 ACAN CCDC15 CKAP2L	1.41e-04	171	129	5	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 ARSJ ITGA1 PCDH11X ROS1	1.45e-04	172	129	5	adc09c4d1b63fe84150516beb692db1e7f7ac980
ToppCell	390C-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ATAD2 HROB PABPC3 CKAP2L EPHA1	1.45e-04	172	129	5	6fcc16f1067672967ecbcdfdc727649ae9891dd9
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATP6V1B1 DDX31 INPPL1 NOXA1 UGT8	1.45e-04	172	129	5	1bbf5ed7d13635f9a7e528060341e0652699bd7c
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Adult / Lineage, Cell type, age group and donor	ASPHD2 F5 FREM1 PAH UNC79	1.57e-04	175	129	5	4db1a3c284488b3f6de7568363f176d74e2a4587
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231\|Adult / Lineage, Cell type, age group and donor	ASPHD2 F5 FREM1 PAH UNC79	1.57e-04	175	129	5	8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 ARSJ ITGA1 PCDH11X ROS1	1.61e-04	176	129	5	ed421d8525108d2f585265d2cf777f07b29f44f0
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DRP2 PCDHGA7 AATK UGT8 CSMD1	1.65e-04	177	129	5	59cf56c385c324f0844f20003d2b5049a2791e45
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 ARSJ ABO GALNT16 PCDH11X	1.65e-04	177	129	5	4c069f0d044a96118090b85ca592a21d6b5d9399
ToppCell	NS-moderate-d_0-4-Epithelial-Basal\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PRICKLE1 PCDHGA9 PAPLN	1.67e-04	37	129	3	e41e6d3bad3135f3f9109312a2ad6f3206d21d6c
ToppCell	droplet-Fat-SCAT-30m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRP2 PIWIL1 AATK UGT8 PCDHGC3	1.70e-04	178	129	5	5cf12927f0756c4d8a289fe4308d736382e6212e
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARSJ ABO MNX1 PIWIL1 F5	1.74e-04	179	129	5	d70791d2a0db35a6b013fa7ed2f9f39364581eff
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DCHS2 PRICKLE1 ITGA1 KIRREL1 DCBLD2	1.74e-04	179	129	5	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHGA6 ETV4 PCDH11X DCBLD2 EPHA1	1.74e-04	179	129	5	e880c507f11ce75d104593a4ca29f0295f8125e8
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 ARSJ ABO GALNT16 PCDH11X	1.83e-04	181	129	5	08f44323bf71b6004a921bbc969c954c75feeb66
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP32 PRICKLE1 CILK1 ITGA1 F8	1.83e-04	181	129	5	fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MPP3 DCHS2 ITGA1 F5 KIRREL1	1.83e-04	181	129	5	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MPP3 DCHS2 ITGA1 F5 KIRREL1	1.83e-04	181	129	5	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIWIL1 AATK UGT8 CSMD1 UNC79	1.88e-04	182	129	5	d568a8aec7e27ce632e248baea2ccd0e8dd255ac
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-B\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDHGC4 PCDHGB5 PCDHGA9 EIF3L PCDHGC3	1.88e-04	182	129	5	a9948a30c6297bd236588148937f294985221986
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIWIL1 AATK UGT8 CSMD1 UNC79	1.88e-04	182	129	5	e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIWIL1 AATK UGT8 CSMD1 UNC79	1.88e-04	182	129	5	82ca6d5ed48b4c487ce00b9309255abb8f20b61d
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP3 PRICKLE1 ITGA1 F8 PCDHGA12	1.93e-04	183	129	5	709a486154b3157427deb3b8886b63ac39ea42dd
ToppCell	droplet-Liver-nan-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP3 PRICKLE1 ITGA1 F8 PCDHGA12	1.93e-04	183	129	5	dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIWIL1 RNASE12 AATK CSMD1 UNC79	1.93e-04	183	129	5	2cf36ad89584eb9f8b04de52a1b511b7f3527884
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DCHS2 ARSJ CKAP2L UGT8 ARHGEF37	1.93e-04	183	129	5	91079a11685dd466bd27a0cf5afbf3734c08a05e
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIWIL1 RNASE12 AATK CSMD1 UNC79	1.93e-04	183	129	5	98fee6838acfaee5e2e449ba088764ec06b8bc57
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PAPPA2 ETV4 RFX2 UGT8 KIRREL1	1.98e-04	184	129	5	8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b
ToppCell	droplet-Limb_Muscle-nan-3m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIWIL1 RNASE12 AATK CSMD1 UNC79	1.98e-04	184	129	5	da8d6e7944eb35e6cbea2feb7cbc2894787d723f
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PAPPA2 ITGA1 F5 GALNT16 ACAN	2.03e-04	185	129	5	35d39a1d04c871edcfb749653538dc5fd0054281
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRP2 MYRFL AATK UGT8 CSMD1	2.03e-04	185	129	5	11c147f3f5570c4761d2bcff3bad28146b4a5861
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRICKLE1 PAPLN CUBN ZNF462 HYDIN	2.08e-04	186	129	5	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCDHGC5 ITGA1 GALNT16 MPRIP ACAN	2.08e-04	186	129	5	0b2ce9b8a4382d583240647217ad5e2d3fa555c1
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGA1 GALNT16 MPRIP ACAN DCBLD2	2.13e-04	187	129	5	b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDHGB7 PCDHGB2 PCDHGB4 CSMD1 PCDHGC3	2.13e-04	187	129	5	6c43669e19b5b54d72d1f5d876184fee53c05f0b
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRICKLE1 PCDHGA10 PCDHGA3 ITGA1 F8	2.19e-04	188	129	5	0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559
Drug	CID9959010	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGA10 PCDHGA3 PCDHGA2 RFX1 PCDHGA12 PCDHGC3 PCDHGA8	1.43e-14	39	130	10	CID009959010
Drug	montmorillonite	ARSJ PCDHGC5 PCDHGC4 PCDHGB7 PCDHGA10 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGC3 PCDHGA8	1.90e-14	40	130	10	CID000517273
Drug	AC1L1UVI	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGA10 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGC3 PCDHGA8	2.48e-11	55	130	9	CID000061263
Drug	lactofen	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGA10 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGC3 PCDHGA8	8.99e-10	81	130	9	CID000062276
Drug	BCNU	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGA10 PCDHGA3 PCDHGA2 INPPL1 PCDHGA12 UGT8 PCDHGC3 PCDHGA8	8.53e-08	229	130	11	CID000002578
Drug	AC1NFC6P	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGA10 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGC3 PCDHGA8	1.83e-07	148	130	9	CID000004587
Drug	3-deoxyhexonic acid	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGA10 PCDHGA3 PCDHGA2 ATAD2 UBA1 PCDHGA12 PCDHGC3 PCDHGA8	1.99e-07	249	130	11	CID000010350
Drug	ss,ss-carotene	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGA10 PCDHGA3 PCDHGA2 PCDHGA12 ROS1 PCDHGC3 PCDHGA8	2.44e-07	201	130	10	CID000000573
Drug	sertaconazole	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGA10 PCDHGA3 PCDHGA2 PCDHGA12 BRD1 PCDHGC3 PCDHGA8	5.61e-07	220	130	10	CID000065863
Drug	sulfite	ATP6V1B1 PCDHGC5 PCDHGC4 PCDHGB7 PCDHGA10 PCDHGA3 PCDHGA2 NF1 PCDHGA12 PCDH11X CSMD1 PCDHGC3 PCDHGA8	1.41e-06	438	130	13	CID000001099
Drug	AC1L7AJI	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGA10 PCDHGA3 PCDHGA2 CPT2 PCDHGA12 PCDHGC3 PCDHGA8	2.21e-06	256	130	10	CID000003750
Drug	Sp 1 (pharmaceutical)	PCDHGC5 PCDHGC4 PCDHGB7 MNX1 PCDHGA10 PCDHGA3 PCDHGA2 ESR1 ETV4 NF1 PCDHGA12 PCDHGC3 PCDHGA8	1.58e-05	548	130	13	CID000099040
Drug	Fillalbin [4540-25-4]; Up 200; 13.8uM; PC3; HT_HG-U133A	MPP3 PAPPA2 GPLD1 DRP2 ESR1 HROB ACAN TNS1	1.61e-05	194	130	8	4092_UP
Drug	Cefaclor [70356-03-5]; Down 200; 10.4uM; PC3; HT_HG-U133A	SZT2 ESR1 CPT2 EZH1 HROB MYO1F KIRREL1 TNS1	1.86e-05	198	130	8	6622_DN
Drug	1a-h	ESR1 NF1	3.24e-05	2	130	2	CID011513133
Drug	2a-h	ESR1 NF1	3.24e-05	2	130	2	CID011650493
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGB4 PCDHGC3 PCDHGA8	1.33e-31	71	125	20	EFO_0007878, EFO_0007979
Disease	mental development measurement	PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGB4 PCDHGA8	3.36e-30	25	125	15	EFO_0008230
Disease	Sarcosine measurement	PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGB4 PCDHGA8	2.52e-23	23	125	12	EFO_0021668
Disease	mean platelet volume	MPP3 ARHGAP32 ABO PCDHGC5 PCDHGC4 PCDHGB7 MYO1E PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 RFX2 MPRIP PCDHGA12 PCDHGB4 CKAP2L ARHGEF3 BRD1 PCDHGC3 PCDHGA8	2.56e-16	1020	125	29	EFO_0004584
Disease	lymphocyte count	ABO PCDHGC5 PCDHGC4 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 RNASE12 ITGA1 PCDHGA12 PCDHGB4 KIRREL1 ARHGEF3 PCDHGC3 HNRNPLL PCDHGA8	4.26e-10	1464	125	26	EFO_0004587
Disease	galectin-4 measurement	ABO ARHGEF3	1.06e-04	4	125	2	EFO_0020398
Disease	platelet endothelial aggregation receptor 1 measurement	ABO ARHGEF3	1.06e-04	4	125	2	EFO_0801886
Disease	uncharacterized protein KIAA0040 measurement	F5 ARHGEF3	1.06e-04	4	125	2	EFO_0802196
Disease	venous thromboembolism, response to surgery	ABO CSMD1	1.06e-04	4	125	2	EFO_0004286, EFO_0009951
Disease	scavenger receptor class F member 1 measurement	PRPF8 ARHGEF3	1.77e-04	5	125	2	EFO_0008276
Disease	chronotype measurement, sun exposure measurement	ARSJ UGT8	1.77e-04	5	125	2	EFO_0008328, EFO_0010729
Disease	semaphorin-6B measurement	SEMA6B ABO	1.77e-04	5	125	2	EFO_0021885
Disease	Alzheimer disease, polygenic risk score	PCDHGB2 PCDHGB1 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 LARP4 BRD1 HYDIN	2.03e-04	586	125	10	EFO_0030082, MONDO_0004975
Disease	respiratory failure, COVID-19	ABO FREM1 DPP9	2.50e-04	29	125	3	EFO_0009686, MONDO_0100096
Disease	alkaline phosphatase measurement, liver enzyme measurement	GPLD1 ABO	2.64e-04	6	125	2	EFO_0004533, EFO_0004582
Disease	peripheral vascular disease	ABO F5	3.69e-04	7	125	2	EFO_0003875
Disease	X-26054 measurement	ABO C4orf33	3.69e-04	7	125	2	EFO_0800939
Disease	platelet reactivity measurement	ABO ARHGEF3	3.69e-04	7	125	2	EFO_0004985
Disease	free cholesterol in medium LDL measurement	TDRD15 ABO ITGA1	6.54e-04	40	125	3	EFO_0022268
Disease	venous thromboembolism, von Willebrand factor measurement	DDX31 ABO F5	7.55e-04	42	125	3	EFO_0004286, EFO_0004629
Disease	optic disc area measurement	ARSJ F5 UGT8	9.25e-04	45	125	3	EFO_0006937
Disease	chemotherapy-induced alopecia, response to antimicrotubule agent	PCDHGA5 ZNF462	9.55e-04	11	125	2	EFO_0005260, EFO_0005400
Disease	homocysteine measurement	DCHS2 CUBN CSMD1	9.86e-04	46	125	3	EFO_0004578
Disease	pyruvate measurement	ABO ACAN MYO1F PCDHGB4 ARHGEF3 HYDIN	1.01e-03	268	125	6	EFO_0010117
Disease	phospholipids in medium LDL measurement	TDRD15 ABO ITGA1	1.19e-03	49	125	3	EFO_0022183
Disease	free cholesterol in LDL measurement	TDRD15 ABO ITGA1	1.26e-03	50	125	3	EFO_0022266
Disease	free cholesterol in large LDL measurement	TDRD15 ABO ITGA1	1.33e-03	51	125	3	EFO_0022176
Disease	total lipids in LDL measurement	TDRD15 ABO ITGA1	1.41e-03	52	125	3	EFO_0022308
Disease	Drug habituation	PIWIL1 TENM2 CSRNP3 CSMD1	1.48e-03	115	125	4	C0013170
Disease	Drug abuse	PIWIL1 TENM2 CSRNP3 CSMD1	1.48e-03	115	125	4	C0013146
Disease	Prescription Drug Abuse	PIWIL1 TENM2 CSRNP3 CSMD1	1.48e-03	115	125	4	C4316881
Disease	Substance-Related Disorders	PIWIL1 TENM2 CSRNP3 CSMD1	1.48e-03	115	125	4	C0236969
Disease	Drug Use Disorders	PIWIL1 TENM2 CSRNP3 CSMD1	1.48e-03	115	125	4	C0013222
Disease	Drug Dependence	PIWIL1 TENM2 CSRNP3 CSMD1	1.48e-03	115	125	4	C1510472
Disease	Substance Dependence	PIWIL1 TENM2 CSRNP3 CSMD1	1.48e-03	115	125	4	C0038580
Disease	Substance Use Disorders	PIWIL1 TENM2 CSRNP3 CSMD1	1.48e-03	115	125	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	PIWIL1 TENM2 CSRNP3 CSMD1	1.48e-03	115	125	4	C0029231
Disease	phospholipids in large LDL measurement	TDRD15 ABO ITGA1	1.49e-03	53	125	3	EFO_0022174
Disease	free cholesterol in small LDL measurement	TDRD15 ABO ITGA1	1.49e-03	53	125	3	EFO_0022271
Disease	Substance abuse problem	PIWIL1 TENM2 CSRNP3 CSMD1	1.52e-03	116	125	4	C0740858
Disease	glucose-dependent insulinotropic peptide measurement, glucose tolerance test	PAPPA2 ABO	1.57e-03	14	125	2	EFO_0004307, EFO_0008464
Disease	Acute Cerebrovascular Accidents	ABO PRPF8 F5	1.57e-03	54	125	3	C0751956
Disease	Antithrombotic agent use measurement	TDRD15 ABO F5	1.66e-03	55	125	3	EFO_0009925
Disease	spine bone mineral density	DCHS2 PCBP3 ESR1 CSRNP3	1.67e-03	119	125	4	EFO_0007701
Disease	cholesteryl esters to total lipids in large VLDL percentage	MPP3 TDRD15 ABO	1.75e-03	56	125	3	EFO_0022250
Disease	total lipids in large LDL	TDRD15 ABO ITGA1	1.84e-03	57	125	3	EFO_0022163
Disease	cholesterol in large LDL measurement	TDRD15 ABO ITGA1	1.84e-03	57	125	3	EFO_0021901
Disease	phospholipids in LDL measurement	TDRD15 ABO ITGA1	1.93e-03	58	125	3	EFO_0022294
Disease	phospholipids in small LDL measurement	TDRD15 ABO ITGA1	2.03e-03	59	125	3	EFO_0022297
Disease	free cholesterol to total lipids in very large VLDL percentage	MPP3 TDRD15 ABO	2.03e-03	59	125	3	EFO_0022289
Disease	interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement	ABO F5	2.05e-03	16	125	2	EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293
Disease	amygdala volume change measurement	PKD1L1 CSMD1	2.05e-03	16	125	2	EFO_0021490
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	TDRD15 ABO	2.32e-03	17	125	2	EFO_0022232
Disease	Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism	ABO F5	2.32e-03	17	125	2	EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140
Disease	Cerebrovascular accident	ABO PRPF8 F5	2.34e-03	62	125	3	C0038454
Disease	Ischemic stroke	DCHS2 ABO GALNT1 HTR3A PRPF8 F5	2.63e-03	324	125	6	HP_0002140
Disease	Usual Interstitial Pneumonia	ESR1 DPP9	2.90e-03	19	125	2	C4721509
Disease	Hamman-Rich Disease	ESR1 DPP9	2.90e-03	19	125	2	C4721508
Disease	total lipids in small VLDL	MPP3 TDRD15 ABO	2.92e-03	67	125	3	EFO_0022148
Disease	venous thromboembolism, fibrinogen measurement	DCHS2 ABO F5	2.92e-03	67	125	3	EFO_0004286, EFO_0004623
Disease	sucrose liking measurement	SYNDIG1 PCDHGB4	3.22e-03	20	125	2	EFO_0010157
Disease	Craniosynostosis	FREM1 ZNF462	3.22e-03	20	125	2	C0010278
Disease	Familial Idiopathic Pulmonary Fibrosis	ESR1 DPP9	3.22e-03	20	125	2	C4721952
Disease	Deep Vein Thrombosis	F5 F8	3.55e-03	21	125	2	C0149871
Disease	skin hydration measurement	PIWIL1 PKD1L1	3.55e-03	21	125	2	EFO_0009586
Disease	lung cancer	TENM2 CSMD1	3.55e-03	21	125	2	MONDO_0008903
Disease	Venous Thrombosis	F5 F8	3.55e-03	21	125	2	C0042487
Disease	venous thromboembolism, plasminogen activator inhibitor 1 measurement	ABO F5	3.55e-03	21	125	2	EFO_0004286, EFO_0004792
Disease	vitiligo (is_implicated_in)	ESR1 TYR	3.55e-03	21	125	2	DOID:12306 (is_implicated_in)
Disease	Idiopathic Pulmonary Fibrosis	ESR1 DPP9	3.55e-03	21	125	2	C1800706
Disease	hematocrit	TDRD15 BRPF3 ARSJ ABO RNASE12 ITGA1 MPRIP ZNF462 UGT8 ARHGEF3 HYDIN	3.86e-03	1011	125	11	EFO_0004348
Disease	breast cancer, COVID-19	ABO ESR1	3.89e-03	22	125	2	MONDO_0007254, MONDO_0100096
Disease	lymphocyte count, response to vaccine	SELENOT PIWIL1	3.89e-03	22	125	2	EFO_0004587, EFO_0004645
Disease	Amphetamine-Related Disorders	HTR3A CUBN CSMD1	4.01e-03	75	125	3	C0236733
Disease	Amphetamine Abuse	HTR3A CUBN CSMD1	4.01e-03	75	125	3	C0236807
Disease	Amphetamine Addiction	HTR3A CUBN CSMD1	4.01e-03	75	125	3	C0236804

Protein segments in the cluster

Peptide	Gene	Start	Entry
VYPYLPHVVNQGTRA	ERVPABLB-1	306	P60509
TPAVHVNGLEPYANY	EPHA1	401	P21709
VHQECYGVPYIPEGQ	BRD1	241	O95696
YEALYPVPQHELQQG	C4orf33	146	Q8N1A6
HNEQLCYQLYRQPIP	ARHGEF3	366	Q9NR81
RVHYYVFTDQPAAVP	ABO	146	P16442
VLSPNYPHNYTAGQI	CSMD1	1636	Q96PZ7
HEYNLDIPEGPAVQY	ARHGEF37	306	A1IGU5
YSHPYPGVQDQEQAT	ABCA12	1966	Q86UK0
PLQGYYQVRRPSHEG	ADGRL1	1436	O94910
SPNIPYVYIRHQGEV	HTR3A	131	P46098
NLAVHQECYGVPYIP	BRPF3	236	Q9ULD4
QRIVQQYHPSNNGEY	AP1AR	131	Q63HQ0
ATVYYQAPLEKPRHQ	ATAD2	301	Q6PL18
PELYLDPAYGQINHN	CPT2	571	P23786
KQEYHDPLYEQAGQP	ETV4	226	P43268
HPYNFPEGNALTYIR	GALNT16	351	Q8N428
HYPPYLQERVVNSQY	RC3H1	641	Q5TC82
GGRPVLYQVVAQHSY	NOXA1	396	Q86UR1
QHVPDYRQNVYIPGS	PCDHGA7	886	Q9Y5G6
QHVPDYRQNVYIPGS	PCDHGA2	886	Q9Y5H1
LNHYQIRVPNGSNPY	HNRNPLL	516	Q8WVV9
ARYGPQFTLQHVPDY	PCDHGA5	876	Q9Y5G8
HVPDYRQNVYIPGSN	PCDHGA5	886	Q9Y5G8
QHVPDYRQNVYIPGS	PCDHGA8	886	Q9Y5G5
QHVPDYRQNVYIPGS	PCDHGA12	886	O60330
LQHVPDYRQNVYIPG	PCDHGB4	876	Q9UN71
YGPQFTLQHVPDYRQ	PCDHGB7	876	Q9Y5F8
TLQHVPDYRQNVYIP	PCDHGB7	881	Q9Y5F8
GQPIQVVYVPSHLYH	PDK1	261	Q15118
RHSYQVYRQPIPVQE	NET1	421	Q7Z628
QHVPDYRQNVYIPGS	PCDHGA4	916	Q9Y5G9
QHVPDYRQNVYIPGS	PCDHGA6	886	Q9Y5G7
VTEYPVQRNYGFQIH	MPRIP	441	Q6WCQ1
HNIYVQAINYPTVPR	ALAS1	551	P13196
ITGHGYPDPNYLQNV	DTX2	591	Q86UW9
LSPVVPNYDNVHPNY	EIF3L	421	Q9Y262
AGQHPALSYSYPQVQ	MNX1	176	P50219
LYIAYQAVHSPLQAP	ARSJ	261	Q5FYB0
YYQIDSHIPGTPNQI	CSRNP3	436	Q8WYN3
LQPHGQQVPYYLENE	ESR1	121	P03372
QHVPDYRQNVYIPGS	PCDHGA9	886	Q9Y5G4
ARYGPQFTLQHVPDY	PCDHGA10	881	Q9Y5H3
HVPDYRQNVYIPGSN	PCDHGA10	891	Q9Y5H3
QHVPDYRQNVYIPGS	PCDHGB1	881	Q9Y5G3
ARYGPQFTLQHVPDY	PCDHGB2	876	Q9Y5G2
HVPDYRQNVYIPGSN	PCDHGB2	886	Q9Y5G2
YGPQFTLQHVPDYRQ	PCDHGC5	891	Q9Y5F6
TLQHVPDYRQNVYIP	PCDHGC5	896	Q9Y5F6
QIEYVHYPGVPITNF	FREM1	1441	Q5H8C1
YNYNIPVNKHTPTNV	MYRFL	796	Q96LU7
YLNVTPNNLVHIYSP	HROB	561	Q8N3J3
GEPYYILQHPNILQC	LMTK2	186	Q8IWU2
NQASRPYNIYPHGIT	F8	486	P00451
LQHVPDYRQNVYIPG	PCDHGB5	876	Q9Y5G0
YGPQFTLQHVPDYRQ	PCDHGB3	876	Q9Y5G1
TLQHVPDYRQNVYIP	PCDHGB3	881	Q9Y5G1
YGPQFTLQHVPDYRQ	PCDHGC3	881	Q9UN70
TLQHVPDYRQNVYIP	PCDHGC3	886	Q9UN70
LQHVPDYRQNVYIPG	PCDHGC4	891	Q9Y5F7
THNEYNFYVPENLPR	PCDH11X	571	Q9BZA7
VQYNAPSSPAEYIHR	DDX31	601	Q9H8H2
LYIAGQPRYNHTGQV	ITGA1	451	P56199
NVERDPSVLYQYQPH	ARHGAP32	1996	A7KAX9
FADIAYNYRHGQPIP	PAH	161	P00439
QNHAAYYPPSQIARL	PABPC3	411	Q9H361
AYTIQGQYAIPHPDQ	PCBP3	226	P57721
RTVYVHANQTGYPDP	ACAN	326	P16112
IQYYIESHNPGTNPF	DCHS2	1546	Q6V1P9
PNRPGVYTNISVYFH	PRSS41	276	Q7RTY9
QHVPDYRQNVYIPGS	PCDHGA3	886	Q9Y5H0
QLLYQLPPHDNEVRY	PRICKLE1	71	Q96MT3
GNYLRPYPVGEQEIH	PAPPA2	76	Q9BXP8
LESIGYPNPYSENQH	CUBN	1291	O60494
ENIYPDSQIPRHYFS	GALNT1	416	Q10472
YHVGREQPRPYVSVN	ASPHD2	76	Q6ICH7
HQQNKPYEITYRPRT	HYDIN	4681	Q4G0P3
PFQGYEHRQLRYQQP	ADAR	16	P55265
IPGVPIMYISNHRYN	FCF1	171	Q9Y324
AGKPYQLQIYPNERH	DPP9	826	Q86TI2
PVQENANSGYYEAHP	G3BP2	166	Q9UN86
DIAPSNHYSLQRYPG	UGT8	61	Q16880
HPIQVFYTKQPQNDY	DHX33	256	Q9H6R0
PSQYHNYTQPRGNFI	ABCA2	1491	Q9BZC7
YSHPIQTQAQYASPV	LARP4	291	Q71RC2
PTNGYYNVRAHEDRP	KIRREL1	601	Q96J84
NSPGQEVYHAYAEPL	DCBLD2	656	Q96PD2
RYHIYNVNEENPGFP	GRK1	276	Q15835
HVDYPQNDVPVPARY	RNASE12	31	Q5GAN4
PPNRYLAKAVNYTVH	PKD1L1	1671	Q8TDX9
AISPNKVPYYINHQA	DRP2	361	Q13474
ARYGPQFTLQHVPDY	PCDHGA1	876	Q9Y5H4
HVPDYRQNVYIPGSN	PCDHGA1	886	Q9Y5H4
YEEVARYQHQPGERP	MPP3	371	Q13368
NYYNPNDPIDIPSHR	PIWIL1	231	Q96J94
PTPLIAAHQLYNYVA	SZT2	3101	Q5T011
ENAENPIYPVIHRQY	AK9	1366	Q5TCS8
IYVDRQLHNRQIYPP	ATP6V1B1	371	P15313
IEGENYLPQPIYRHI	SELENOT	71	P62341
QDGVYVLHPQYRTSQ	SERAC1	376	Q96JX3
HQQSPYQLLFGEPYI	TRMT2B	291	Q96GJ1
VNYYSAVTPHLRNQP	PTBP2	111	Q9UKA9
AVTPHLRNQPIYIQY	PTBP2	116	Q9UKA9
SVYPAPQYQSHRVGA	SYNDIG1	41	Q9H7V2
NYRHNVINKPSPVTY	TDRD15	1176	B5MCY1
GLYQTVPPEEHYQTF	F5	1116	P12259
QPYPQHSDQQVLAYT	AATK	336	Q6ZMQ8
PVPHVYSSQVQYVEG	RFX1	286	P22670
VQPVQHVYPAQVQYV	RFX2	61	P48378
VYQPPIHFQNSEFYG	ENTPD4	416	Q9Y227
FNNPAYYVLEGVPHQ	INPPL1	981	O15357
THTSIGYIRNIYNPP	TENM2	1976	Q9NT68
HAHPQEVYNEYVPRG	SLC39A6	521	Q13433
HLYGYQQPRTPRFTN	AMMECR1	141	Q9Y4X0
YHQYVVPKIQDQDSP	CCDC15	696	Q0P6D6
SQALRYPYFQVGHPL	CILK1	276	Q9UPZ9
YPSLLQGEYNNRHPN	CKAP2L	336	Q8IYA6
NNPKGYLPSHYERVQ	PRPF8	2246	Q6P2Q9
VAPRDYLNHYPVFVG	SEMA6B	36	Q9H3T3
YTQYQPRVLAVIGPH	TAS1R3	131	Q7RTX0
QYRQRRFPPYHVGQT	YBX3	231	P16989
VYNPVEEYRRQGLPN	MTM1	166	Q13496
ELISQEPNPGVHYEY	PAPLN	281	O95428
PIGQPSQRRYVHYFS	TNS1	156	Q9HBL0
NYFYVPDLGQVPEIH	WASHC1	231	A8K0Z3
TQVYNYQPCDHPDRP	EZH1	516	Q92800
PFLNASVHYIRENYP	GPLD1	91	P80108
YPEANAPIGHNRESY	TYR	411	P14679
QSVVYHEESPPQYQT	NF1	2686	P21359
PYPAHSNLDVLNYVQ	ROS1	2161	P08922
FSEPLAAPRHQYYNQ	UBA1	936	P22314
DQYPPNIAVKVNHSY	PIAS4	206	Q8N2W9
VYQAVQALYHDPDPS	TNPO3	11	Q9Y5L0
PHQNQYLGEKPYRSS	ZNF418	126	Q8TF45
YSEPPDVQQQLNHYQ	ZNF462	2146	Q96JM2
HKQQGRYPGVSNYQV	NAE1	436	Q13564
QEYHNRVLHNIYPVP	UNC79	16	Q9P2D8
YHQNGVIRNQYVPYP	MYO1E	961	Q12965
IDLYQGAAQYENPPH	MYO1F	71	O00160
GAAQYENPPHIYALT	MYO1F	76	O00160